http://www.webbreakingnews.com/2016/12/16/merck-co-mrk-forecasted-to-post-fy2016-earnings-of-3-76-per-share.html
http://www.reuters.com/article/us-gilead-sciences-merck-co-verdict-idUSKBN1442U9
http://medcitynews.com/2016/12/gilead-merck-2-54b-patent-infringement-case/
https://www.bloomberg.com/news/articles/2016-12-16/gilead-s-patent-loss-to-merck-started-with-a-broken-friendship
http://gulfnews.com/business/economy/jury-orders-gilead-to-pay-merck-2-5b-in-patent-case-1.1947397
http://www.dailypolitical.com/2016/12/16/advisors-asset-management-inc-boosts-stake-in-merck-co-mrk.html
http://www.dailypolitical.com/2016/12/16/merck-co-mrk-shares-bought-by-apg-asset-management-n-v.html
http://www.prnewswire.com/news-releases/milliporesigma-wins-life-science-industry-award-for-most-memorable-advertising-300378241.html
http://www.cnbc.com/2016/12/16/merck-wins-254-billion-in-hepatitis-c-drug-trial-against-gilead.html
http://www.marketwatch.com/story/research-reports-on-drug-makers-equities----pfizer-merck-abbvie-and-johnson-johnson-2016-12-16-718350
http://www.prnewswire.com/news-releases/research-reports-on-drug-makers-equities----pfizer-merck-abbvie-and-johnson--johnson-607055316.html
http://satprnews.com/2016/12/16/european-medicines-agencys-chmp-recommends-mercks-keytruda-pembrolizumab-for-the-first-line-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-whose-tum/
http://www.reuters.com/article/britain-press-ft-idUSL4N1EB05I
http://www.reuters.com/article/britain-press-ft-idUSL4N1EB05I
http://www.prnewswire.com/news-releases/large-cap-pharma-us--eu-outlook-2016-maximizing-their-strength-on-fewer-therapy-class-personalized-medicine-novel-target-and-biosimilars-for-future-growth-300380194.html
http://www.marketwatch.com/story/large-cap-pharma-us-eu-outlook-2016-maximizing-their-strength-on-fewer-therapy-class-personalized-medicine-novel-target-and-biosimilars-for-future-growth-2016-12-16
http://economictimes.indiatimes.com/news/international/business/merck-wins-record-2-5-billion-patent-verdict-against-gilead/articleshow/56028279.cms
http://www.businessinsurance.com/article/20161216/NEWS06/912311026/Merck-wins-hepatitis-C-drug-trial-against-Gilead-Sovaldi-Harvoni
http://www.proactiveinvestors.com/companies/news/170613/merck-s-keytruda-close-to-europe-approval-as-chemotherapy-alternative-170613.html
http://satprnews.com/2016/12/16/glaucoma-therapeutics-market-global-industry-analysis-2016-2024/
http://www.industryweek.com/intellectual-property/merck-wins-record-25-billion-patent-verdict-against-gilead
http://www.prnewswire.com/news-releases/europe-neurological-disorder-drugs-market-is-expected-to-reach-us320-billion-by-2024-cerebrovascular-disease-to-assume-lead-in-forthcoming-years-predicts-tmr-607046906.html
http://www.prnewswire.co.uk/news-releases/europe-neurological-disorder-drugs-market-is-expected-to-reach-us320-billion-by-2024-cerebrovascular-disease-to-assume-lead-in-forthcoming-years-predicts-tmr-607046876.html
http://satprnews.com/2016/12/16/europe-neurological-disorder-drugs-market-is-expected-to-reach-us32-0-billion-by-2024-cerebrovascular-disease-to-assume-lead-in-forthcoming-years-predicts-tmr/
https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm?s_cid=mm6549a5_x
https://de.finance.yahoo.com/nachrichten/kind-cancer-treatment-works-remarkably-120000022.html
http://www.businessinsider.com/how-cancer-immunotherapy-works-2016-12
http://www.fool.com/investing/2016/12/17/3-biggest-risks-for-incyte-corporation.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.fool.com/investing/2016/12/17/3-biggest-risks-for-incyte-corporation.aspx
http://www.crainscleveland.com/article/20161217/NEWSMAKERS16/161219849/newsmaker-of-the-year-changing-face-of-c-suites
http://www.thegazette.com/subject/news/health/eli-lilly-announces-price-break-on-insulin-20161213
https://consumerist.com/2016/12/16/the-epipen-generic-is-finally-here-for-300-per-twin-pack/
http://www.theweek.co.uk/79840/actavis-accused-of-overcharging-nhs-for-life-saving-drug
http://markets.businessinsider.com/news/stocks/10-things-you-need-to-know-before-the-opening-bell-1001610242
http://www.northdevonjournal.co.uk/actavis-uk-accused-of-overcharging-the-nhs-for-a-lifesaving-drug/story-29988390-detail/story.html
http://www.emailwire.com/release/313563-Asthma-Drugs-Market-Size-Sales-Share-Growth-Analysis-Trends-and-Forecast-2016-2021-in-Europe.html
http://www.emailwire.com/release/313586-Myocardial-Infarction-Therapeutics-Global-Market-By-Product-Data-Validation-Analysis-and-Forecast-2022.html
http://www.cei.asia/article/events-need-to-evolve-icesap-2016/432470
http://www.emailwire.com/release/314493-Malaria-Comparative-Analysis-by-Clinical-Stage-Development-H2-2016-.html
http://satprnews.com/2016/12/17/u-s-bacterial-conjunctivitis-market-drivers-and-restraints-2024/
http://www.emailwire.com/release/313940--Central-Nervous-System-Disorders-Therapeutics-Market-2016-Analysis-and-Forecast-2020.html
http://www.bangkokpost.com/news/world/1161457/us-stocks-gain-at-open-oil-shares-strong
http://satprnews.com/2016/12/16/asia-pacific-anti-inflammatory-therapeutics-market-is-expected-to-grow-at-a-cagr-of-8-6-over-the-forecast-period/
http://satprnews.com/2016/12/16/world-active-pharmaceutical-ingredients-market-6-61-cagr-during-2017-to-2021/
http://www.flicksandbits.com/market-analysiscompetitive-landscape-depth-report-human-chorionic-gonadotropin-market-2016-2022-credence-research/
http://www.rundirectmagazine.com/next-generation-sequencing-market-is-growing-with-the-cagr-of-21-2-during-2015-2022-brisk-insights-2/41494/
http://www.flicksandbits.com/next-generation-sequencing-market-global-industry-analysis-industry-outlook-strategies-2022/
http://www.manufacturingchemist.com/news/article_page/Almac_Group_collaborates_with_Exostar_to_extend_clinical_trials_identity_management/123924
http://satprnews.com/2016/12/16/veterinary-vaccines-market-expected-to-reach-us-7-24-bn-in-2016/
https://www.bloomberg.com/news/articles/2016-12-15/american-blood-gives-a-boost-to-asia-s-most-valuable-drugmaker
http://www.themalaymailonline.com/money/article/american-blood-gives-boost-to-asias-most-valuable-drugmaker
http://www.emailwire.com/release/314496-Gliosarcoma-Development-by-Companies-H2-2016.html
http://satprnews.com/2016/12/17/global-opportunity-in-the-u-s-and-china-asthma-and-copd-drugs-market/
http://www.mmm-online.com/roundup/five-things-for-pharma-marketers-to-know-friday-december-16-2016/article/579673/
http://www.prnewswire.com/news-releases/vaccines-the-world-market-300380459.html
http://www.emailwire.com/release/313884-Liver-Cirrhosis-Market-Review-H1-2016-Growth-Analysis-Trends-Forecasts.html
http://buffalonews.com/2016/12/16/roswell-ovarian-cancer-study-test-three-drug-combo/
http://satprnews.com/2016/12/16/human-vaccines-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2024-2/
http://satprnews.com/2016/12/16/respiratory-inhaler-devices-market-demand-is-increasing-rapidly-in-recent-years/
http://satprnews.com/2016/12/16/human-vaccines-market-global-industry-analysis-2016-2024/
